Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Sirolimus
DRUG: Celecoxib
DRUG: Etoposide
DRUG: Cyclophosphamide

Sponsor

Emory University

Collaborators

[object Object]
[object Object]